Target intelligence / Profile preview

Extended synaptotagmin-1 (E-Syt1)

Target
E-Syt1
Molecular classification
Lipid transfer protein, Tethering protein, Endoplasmic reticulum-plasma membrane (ER–PM) contact site protein, Membrane contact site protein, Other (contains synaptotagmin-like mitochondrial-lipid-binding protein/SMP domain, and C2 domains)
01

Overview

Extended synaptotagmin-1 (E-Syt1) is an evolutionarily conserved lipid transfer and membrane tethering protein localized to the endoplasmic reticulum (ER), where it plays a pivotal role in tethering the ER to the plasma membrane (PM) at membrane contact sites. E-Syt1 contains an N-terminal ER anchoring segment, a central synaptotagmin-like mitochondrial-lipid-binding protein (SMP) domain that mediates non-vesicular lipid transfer, and five C-terminal C2 domains which interact with acidic phospholipids at the PM in a calcium-dependent manner[5][8][1][3][2]. E-Syt1 is critical for regulating local lipid composition (such as diacylglycerol and phosphoinositides) and maintaining structural and signaling integrity at ER–PM contacts. Although E-Syt1 is not directly implicated as a conventional drug target, its central role in membrane biology and cell signaling—particularly in T cell function and neural tissue integrity—highlights its importance in fundamental cell physiology and as a potential target for modulation in diseases related to cell signaling defects and membrane dynamics[5][7][8][6].

Other names
ESYT1E-Syt1Extended synaptotagmin Itricalbin-1 (in yeast orthologs)dEsyt (in Drosophila)
02

Mechanism of action

Not directly targeted by drugs; hypothetical mechanisms would target lipid transfer, ER–PM tethering, or calcium-regulated activity at membrane contact sites

03

Biological functions

Lipid transport/shuttling at ER–PM contact sitesTethering of endoplasmic reticulum (ER) to plasma membrane (PM)Calcium-dependent membrane interactionsRegulation of phospholipid and signaling lipid distribution (e.g., diacylglycerol/DAG homeostasis)Modulation of T cell receptor signaling and effector functions
04

Disease associations

Neurodegenerative disease (by analogy with synaptic and membrane regulation, though less direct evidence for E-Syt1 itself)Immune dysregulation/Autoimmune disease (through T cell signaling modulation)Retinal degeneration (described in Drosophila)Other (general cell signaling and membrane homeostasis defects)
05

Safety considerations

Loss-of-function in Drosophila leads to photoreceptor degeneration, structural synapse loss, and signaling disruption. Complete loss in mammals/yeast can lead to subtle or variable phenotypes; specific safety risks for therapeutic targeting are unknown but may involve widespread membrane homeostasis defects
06

Interacting drugs

None are currently clinically approved or characterized as direct E-Syt1 modulators; no drugs are specifically listed as E-Syt1 ligands
07

Biomarkers

None established for clinical use; potentially ER–PM contact site components or changes in DAG and PIP2 as functional readouts in research settings

Beyond the preview

Go deeper on Extended synaptotagmin-1 (E-Syt1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Extended synaptotagmin-1 (E-Syt1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call